Reassessing therapeutic antibodies for neglected and tropical diseases.

• Үндсэн зохиолчид: Rob Hooft van Huijsduijnen (Зохиогч), Somei Kojima (Зохиогч), Dee Carter (Зохиогч), Hisafumi Okabe (Зохиогч), Akihide Sato (Зохиогч), Wataru Akahata (Зохиогч), Timothy N C Wells (Зохиогч), Kei Katsuno (Зохиогч)
• Формат: Ном
• Хэвлэсэн: Public Library of Science (PLoS), 2020-01-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

In the past two decades there has been a significant expansion in the number of new therapeutic monoclonal antibodies (mAbs) that are approved by regulators. The discovery of these new medicines has been driven primarily by new approaches in inflammatory diseases and oncology, especially in immuno-o...